ConductScience.org, home

Paper · 308987

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.

Hellström KE and 3 others. J Exp Med, 1978. Cited by 118 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population. Papers, record 308987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/308987

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.
PubMed
Journal
J Exp Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2021-12-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hellström KEK E
2Hellström II
3Kant JAJ A
4Tamerius JDJ D

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sarcoma, ExperimentalMajor topic
T-LymphocytesMajor topic
Animals
Gamma Rays
Immunity, Cellular
Immunosuppression Therapy
Mice
Mice, Inbred BALB C
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
175,855Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.Int J Cancer1978https://conductscience.org/library/papers/75855PubMed
269,667Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.J Immunol1977https://conductscience.org/library/papers/69667PubMed
3204,940Antibody response of mice to chemically induced tumors.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/204940PubMed
4197,528Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/197528PubMed
5299,883Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.J Exp Med1977https://conductscience.org/library/papers/299883PubMed
6270,747Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/270747PubMed
7915,269Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells.J Immunol1977https://conductscience.org/library/papers/915269PubMed
84,358,038Cell-mediated destruction of Rous sarcomas in Japanese quails.Int J Cancer1972https://conductscience.org/library/papers/4358038PubMed
94,587,740A rapid method for the isolation of functional thymus-derived murine lymphocytes.Eur J Immunol1973https://conductscience.org/library/papers/4587740PubMed
104,546,445Activation of suppressor T cells by tumour cells and specific antibody.Nature1974https://conductscience.org/library/papers/4546445PubMed

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
42,022,354Mapping the research landscape of the correlation between radiotherapy and tumor immune microenvironment: A bibliometric analysis.Precis Radiat Oncol2026https://conductscience.org/library/papers/42022354PubMed
40,597,275Robo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors.J Transl Med2025https://conductscience.org/library/papers/40597275PubMed
40,289,115Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy.Mol Cancer2025https://conductscience.org/library/papers/40289115PubMed
39,754,357Emerging combined CAR-NK cell therapies in cancer treatment: Finding a dancing partner.Mol Ther2025https://conductscience.org/library/papers/39754357PubMed
38,162,672Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors.Front Immunol2023https://conductscience.org/library/papers/38162672PubMed
33,375,357Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY).Cancers (Basel)2020https://conductscience.org/library/papers/33375357PubMed
29,248,428Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.Mol Ther2018https://conductscience.org/library/papers/29248428PubMed
28,791,251Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization.Front Oncol2017https://conductscience.org/library/papers/28791251PubMed
28,443,099A Century of Radiation Therapy and Adaptive Immunity.Front Immunol2017https://conductscience.org/library/papers/28443099PubMed
28,094,262Radiotherapy and immunotherapy: a beneficial liaison?Nat Rev Clin Oncol2017https://conductscience.org/library/papers/28094262PubMed

1 to 10 of 47

See all 47 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/308987

GET https://conductscience.org/api/papers/v1/308987/cited_by?page=2